Current Roles

Employees:
50
Revenue:
$3.9M
About
Clinical Genomics is a privately held biotechnology company developing innovative products for colorectal cancer diagnosis and monitoring. With a broad intellectual property portfolio including more than 20 issued and pending patents, Clinical Genomics has developed and validated a sensitive and specific blood test for colorectal cancer recurrence monitoring that will be launched in the U.S. in 2016. This 2-gene test, which is based on methylated DNA from two genes, BCAT1 and IKZF1, is currently known by its project name GEMINI.
Clinical Genomics Address
1031 US 202/206
Bridgewater, NJ
United States
Clinical Genomics Email

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.